Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

Completed

• Conditions: Prostate Cancer

• Registration Number: NCT00668083
• Lead Sponsor: AstraZeneca

Brief Summary

Observational Retrospective trial on sequential hormonal therapy in patients with Prostate Cancer

Detailed Description

Not available

Study Timeline

• Study Start: 2007-09
• Primary Completion: 2007-10
• Study First Submitted: 2008-04-24
• Study First Submitted QC: 2008-04-27
• Study First Posted: 2008-04-28
• Study Completion: 2008-07
• Status Verified: 2010-12
• Last Update Submitted: 2010-12-09
• Last Update Posted: 2010-12-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 214

Inclusion Criteria

• non metastatic Prostate Cancer
• previous treatment with bicalutamide 150mg
• biochemical relapse/progression

Read More

Exclusion Criteria

• use of other treatments for Prostate Cancer

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hormonal sensitivity to second line treatment for CaP after Bicalutamide	six months

Secondary Outcome Measures

Name	Time	Method
median duration of second and third line treatments;	six months

Trial Locations

Locations (2)

Research SIte; 🇮🇹 Firenze, Italy

Research Site; 🇮🇹 Viareggio, Italy